| MeSH term | MeSH ID | Detail |
|---|---|---|
| HIV Seropositivity | D006679 | 15 associated lipids |
| Biliary Atresia | D001656 | 4 associated lipids |
| Cachexia | D002100 | 21 associated lipids |
| Addison Disease | D000224 | 3 associated lipids |
| Primary Myelofibrosis | D055728 | 6 associated lipids |
| Alveolar Bone Loss | D016301 | 10 associated lipids |
| Periapical Periodontitis | D010485 | 6 associated lipids |
| Vitamin D Deficiency | D014808 | 13 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
| Vascular Diseases | D014652 | 16 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Wang ST et al. | Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria. | 2013 | Clin. Nephrol. | pmid:23073066 |
| Honma M et al. | RANKL subcellular trafficking and regulatory mechanisms in osteocytes. | 2013 | J. Bone Miner. Res. | pmid:23529793 |
| Jin J et al. | Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL/OPG ratio to impair osteoclast differentiation. | 2013 | J. Surg. Res. | pmid:22487394 |
| Zhan X et al. | Storage media enhance osteoclastogenic potential of human periodontal ligament cells via RANKL-independent signaling. | 2013 | Dent Traumatol | pmid:22487464 |
| Kim J et al. | Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis. | 2013 | Clin. Biochem. | pmid:23726804 |
| Saini V et al. | Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. | 2013 | J. Biol. Chem. | pmid:23729679 |
| Ma XN et al. | [Mechanisms of icariin in regulating bone formation of osteoblasts and bone resorption of osteoclasts]. | 2013 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | pmid:23987492 |
| Naumnik B et al. | Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients. | 2013 | Adv Med Sci | pmid:23959668 |
| Enhos S et al. | OPG and RANKL levels around miniscrew implants during orthodontic tooth movement. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23910201 |
| Callegari A et al. | Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification. | 2013 | Arterioscler. Thromb. Vasc. Biol. | pmid:23990207 |
| Oshita K et al. | [Regulation of osteoclastogenesis by human mesenchymal stem cells leading to application of a novel treatment for rheumatoid arthritis]. | 2013 | J. UOEH | pmid:23475022 |
| Mozzanega B et al. | Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle. | 2013 | J. Bone Miner. Metab. | pmid:23479185 |
| Wang XF et al. | The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients. | 2013 | Mol Med Rep | pmid:23440406 |
| Srivastava S et al. | Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. | 2013 | Phytomedicine | pmid:23570998 |
| Fu YX et al. | Influence of osteoprotegerin on differentiation, activation, and apoptosis of Gaoyou duck embryo osteoclasts in vitro. | 2013 | Poult. Sci. | pmid:23687158 |
| Lou Z et al. | Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone. | 2013 | Med. Oncol. | pmid:23690270 |
| Brown TT et al. | Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals. | 2013 | J. Acquir. Immune Defic. Syndr. | pmid:23591634 |
| Feng X et al. | Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 β -induced RANKL, OPG, TNF α , and IL-6 expression in human rheumatoid synoviocyte MH7A. | 2013 | Clin. Dev. Immunol. | pmid:24348674 |
| Levidou G et al. | TRAIL and osteoprotegerin (OPG) expression in bladder urothelial carcinoma: correlation with clinicopathological parameters and prognosis. | 2013 | Pathology | pmid:23277172 |
| de Moraes M et al. | Immunoexpression of RANK, RANKL, OPG, VEGF, and vWF in radicular and dentigerous cysts. | 2013 | J. Oral Pathol. Med. | pmid:23278112 |
| Zhang W et al. | IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. | 2013 | Inflammation | pmid:22945280 |
| Shao B et al. | [RANKL and OPG expression in bone marrow-derived mesenchymal stem cells of ovariectomied promotes osteoclast development and enhances its function]. | 2013 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | pmid:24321069 |
| Jiang H et al. | A randomized controlled trial of pre-conception treatment for periodontal disease to improve periodontal status during pregnancy and birth outcomes. | 2013 | BMC Pregnancy Childbirth | pmid:24321402 |
| Dorotheou D et al. | Tooth eruption: altered gene expression in the dental follicle of patients with cleidocranial dysplasia. | 2013 | Orthod Craniofac Res | pmid:23311656 |
| Zhang J et al. | Occlusal effects on longitudinal bone alterations of the temporomandibular joint. | 2013 | J. Dent. Res. | pmid:23340211 |
| Kim HS et al. | The flavonoid glabridin attenuates 2-deoxy-D-ribose-induced oxidative damage and cellular dysfunction in MC3T3-E1 osteoblastic cells. | 2013 | Int. J. Mol. Med. | pmid:23128413 |
| Ciccone MM et al. | Serum osteoprotegerin and carotid intima-media thickness in acute/chronic coronary artery diseases. | 2013 | J Cardiovasc Med (Hagerstown) | pmid:22772598 |
| Giganti MG et al. | Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. | 2012 Oct-Dec | J. Biol. Regul. Homeost. Agents | pmid:23241117 |
| Heitzer E et al. | IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. | 2012 Nov-Dec | Pain Physician | pmid:23159968 |
| Nuño-Arana I et al. | Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. | 2012 Jul-Aug | Am. J. Hum. Biol. | pmid:22434650 |
| Varsavsky M et al. | Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. | 2012 Jul-Aug | J. Androl. | pmid:21903971 |
| Dalezis P et al. | Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. | 2012 Jan-Feb | In Vivo | pmid:22210719 |
| Ambroszkiewicz J et al. | [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. | 2012 Apr-Jun | Med Wieku Rozwoj | pmid:22971655 |
| Koch FP et al. | Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. | 2012 | Clin Oral Investig | pmid:20938793 |
| Ozkok A et al. | Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. | 2012 | Clin J Am Soc Nephrol | pmid:22490874 |
| Funck-Brentano T et al. | Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism. | 2012 | PLoS ONE | pmid:22432033 |
| Bilgir O et al. | Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever. | 2012 | Transfus. Apher. Sci. | pmid:22079264 |
| Rojano-MejÃa D et al. | TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women. | 2012 | Maturitas | pmid:22079369 |
| Kühn MC et al. | Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. | 2012 | Mol. Cell. Endocrinol. | pmid:22040599 |
| Pineda B et al. | Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling. | 2012 | Menopause | pmid:22067277 |
| Chuang FH et al. | Long-term sequential receptor activator of NF-κB ligand (RANKL) and osteoprotegrin (OPG) expression in lipopolysaccharide-induced rat periapical lesions. | 2012 | J. Oral Pathol. Med. | pmid:21793936 |
| Rodriguez-Lorenzo LM et al. | Feasibility of ceramic-polymer composite cryogels as scaffolds for bone tissue engineering. | 2012 | J Tissue Eng Regen Med | pmid:21800433 |
| Brambila-Tapia AJ et al. | MTHFR C677T, MTHFR A1298C, and OPG A163G polymorphisms in Mexican patients with rheumatoid arthritis and osteoporosis. | 2012 | Dis. Markers | pmid:22377704 |
| Gimenez-Maitre A et al. | Deficit of osteoprotegerin release by osteoblasts from a patient with cystic fibrosis. | 2012 | Eur. Respir. J. | pmid:22379154 |
| Mao X et al. | Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo. | 2012 | Inflammation | pmid:22391745 |
| Kim H et al. | Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels. | 2012 | Arch. Gynecol. Obstet. | pmid:22392486 |
| Liu S et al. | Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells. | 2012 | Hum. Cell | pmid:22399266 |
| Zhao NN et al. | [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention]. | 2012 | Beijing Da Xue Xue Bao | pmid:22353912 |
| Nonaka CF et al. | Immunohistochemical analysis of bone resorption regulators (RANKL and OPG), angiogenic index, and myofibroblasts in syndrome and non-syndrome odontogenic keratocysts. | 2012 | Arch. Oral Biol. | pmid:21871606 |
| Zheleznyak A et al. | Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. | 2012 | Mol Imaging Biol | pmid:21853370 |
| Dorota DK et al. | The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. | 2012 | Hypertens Pregnancy | pmid:20822429 |
| Wang Y et al. | Inhibitory effect of adenovirus-mediated siRNA-targeting BMPR-IB on UHMWPE-induced bone destruction in the murine air pouch model. | 2012 | Connect. Tissue Res. | pmid:22827452 |
| Zhou WJ et al. | [Expression of receptor activator of NF-κB ligand and osteoprotegerin in peri-implant tissues during unloading period]. | 2012 | Zhonghua Kou Qiang Yi Xue Za Zhi | pmid:22883830 |
| Mayahara K et al. | Osteoblasts stimulate osteoclastogenesis via RANKL expression more strongly than periodontal ligament cells do in response to PGE(2). | 2012 | Arch. Oral Biol. | pmid:22884709 |
| Hosbond SE et al. | Osteoprotegerin as a marker of atherosclerosis: a systematic update. | 2012 | Scand. Cardiovasc. J. | pmid:22506827 |
| Li YF et al. | The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. | 2012 | Osteoporos Int | pmid:21892678 |
| Ohe JY et al. | Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts. | 2012 | Clin Oral Investig | pmid:21938481 |
| Ma Y et al. | Effects of brucine on bone metabolism in multiple myeloma. | 2012 | Mol Med Rep | pmid:22614932 |
| Ma D et al. | Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 mice. | 2012 | J. Proteome Res. | pmid:22616666 |
| Kim EC et al. | Lysyl oxidase and the lysyl oxidase-like protein modulate odontoblastic differentiation of human dental pulp cells. | 2012 | J Endod | pmid:22595110 |
| da Silva RA et al. | Toll-like receptor 2 knockout mice showed increased periapical lesion size and osteoclast number. | 2012 | J Endod | pmid:22595116 |
| Chen WH et al. | Effects of huogu I formula (I) on correlated factors of bone regeneration in chickens with steroid-induced necrosis of femoral head. | 2012 | Chin J Integr Med | pmid:22549392 |
| Zheng D et al. | The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. | 2012 | Bone | pmid:22551876 |
| Wang YD et al. | Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway. | 2012 | Horm. Metab. Res. | pmid:22556124 |
| Larussa T et al. | No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. | 2012 | World J. Gastroenterol. | pmid:22529691 |
| Fichna M et al. | Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution. | 2012 | J. Physiol. Pharmacol. | pmid:23388484 |
| Hou JM et al. | Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22902986 |
| Ma B et al. | Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22426695 |
| Schweikle E et al. | Osteoprotegerin positively regulates hematopoietic progenitor cells. | 2012 | Curr Stem Cell Res Ther | pmid:22023625 |
| GarcÃa-MartÃn A et al. | [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]. | 2012 | Med Clin (Barc) | pmid:22024564 |
| Zijlstra WP et al. | Cobalt and chromium ions reduce human osteoblast-like cell activity in vitro, reduce the OPG to RANKL ratio, and induce oxidative stress. | 2012 | J. Orthop. Res. | pmid:22025323 |
| Zhao N et al. | Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis. | 2012 | Orthod Craniofac Res | pmid:22264323 |
| Erkol A et al. | Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. | 2012 | Atherosclerosis | pmid:22265272 |
| Liu T et al. | [Correlation between local microenvironment leptin expression and avascular necrosis of the femoral head]. | 2012 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:23230665 |
| Li L et al. | [Progress of osteogenic effect of strontium and its application in orthopaedics]. | 2012 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:23230680 |
| Qiu S et al. | [Design and activity verification of human parathyroid hormone (1-34) mutant protein]. | 2012 | Yao Xue Xue Bao | pmid:22993856 |
| Vik A et al. | Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study. | 2012 | Thromb. Res. | pmid:22909822 |
| Dong W et al. | [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts]. | 2012 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:23268391 |
| Feng Y et al. | AMP-activated protein kinase acts as a negative regulator of high glucose-induced RANKL expression in human periodontal ligament cells. | 2012 | Chin. Med. J. | pmid:22964327 |
| Pedersen S et al. | Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. | 2012 | Cardiology | pmid:22964478 |
| Bargman R et al. | High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. | 2012 | Pediatr. Res. | pmid:22926546 |
| Shahnazari M et al. | Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice. | 2012 | Bone | pmid:22154841 |
| Zheng CM et al. | Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients. | 2012 | Tohoku J. Exp. Med. | pmid:22156488 |
| Said F et al. | The effect of etidronate on the periodontium of ovariectomized rats. | 2012 | J. Periodontol. | pmid:22166164 |
| Guo D et al. | Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. | 2012 | Mol. Cell. Biochem. | pmid:22167620 |
| Svensson M et al. | Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. | 2012 | Nephrol. Dial. Transplant. | pmid:22172725 |
| Kraus D et al. | Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro. | 2012 | Clin Oral Investig | pmid:22186940 |
| Zhao N et al. | Local osteoprotegerin gene transfer inhibits relapse of orthodontic tooth movement. | 2012 | Am J Orthod Dentofacial Orthop | pmid:22196183 |
| Upton AR et al. | The expression of RANKL and OPG in the various grades of osteoarthritic cartilage. | 2012 | Rheumatol. Int. | pmid:21259010 |
| Bilgin E et al. | Markers of bone metastases in breast and lung cancers. | 2012 | Asian Pac. J. Cancer Prev. | pmid:23167338 |
| Luo ZR and Xie QJ | [Correlation between osteoprotegerin gene 209G/A, 245T/G and 1181G/C polymorphism and acute coronary syndromes in Han people of Fujian area]. | 2012 | Zhongguo Wei Zhong Bing Ji Jiu Yi Xue | pmid:23168201 |
| Cui L et al. | Effect of fluid flow-induced shear stress on osteoclast formation induced by osteocyte. | 2012 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | pmid:22776650 |
| Li YL and Wang H | [Serum osteoprotegerin level in children with nephrotic syndrome and the effect of glucocorticoid on it]. | 2012 | Zhongguo Dang Dai Er Ke Za Zhi | pmid:22989431 |
| Tyagi AM et al. | Formononetin reverses established osteopenia in adult ovariectomized rats. | 2012 | Menopause | pmid:22781783 |
| Kim IS et al. | Human mesenchymal stromal cells are mechanosensitive to vibration stimuli. | 2012 | J. Dent. Res. | pmid:23086742 |
| Xu Y et al. | [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients]. | 2012 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:22803436 |
| Zhu XF et al. | [Effects of yigu capsule containing serum on the osteoblast differentiation and the expressions of osteoprotegerin and bone morphogenetic protein 2 after treatment by advanced glycation end products in vitro]. | 2012 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:22803437 |
| Davenport C et al. | The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients. | 2012 | Eur. J. Clin. Invest. | pmid:22803952 |
| Mirzaei K et al. | Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. | 2012 | Minerva Med. | pmid:22805623 |
| Belibasakis GN and Bostanci N | The RANKL-OPG system in clinical periodontology. | 2012 | J. Clin. Periodontol. | pmid:22092994 |